Parkinson’s Disease: Early Warning Signs Most People Miss

Parkinson’s Disease at a Glance

What it is: A progressive neurological condition caused by the gradual loss of dopamine-producing neurons in the brain, affecting movement, mood, sleep, and several other body functions.

The critical point: Non-motor symptoms, such as loss of smell, disturbed sleep, constipation, and mood changes, often appear 5 to 10 years before visible signs such as tremors. These early signals are frequently overlooked.

Who is most at risk: Adults over 60, men slightly more than women, individuals with a family history, and increasingly in India, people in their 40s and 50s presenting with early-onset disease.

What to do: If you or a family member notice a combination of these early signs, consult a neurologist. Early diagnosis does not change what the condition is, but it significantly improves how well it can be managed.

The Disease That Announces Itself Years Before You Recognise It

Most people, when they hear “Parkinson’s disease,” picture a trembling hand. That image is not wrong, but it is incomplete, and the incompleteness is precisely what allows the disease to go unrecognised for so long.

By the time a visible tremor appears, Parkinson’s has typically been present and progressing for years, often a decade or more. The early signs are quieter, less obvious, and far easier to attribute to ageing, stress, or an unrelated health issue. A changed sense of smell. Vivid, violent dreams. Handwriting that has quietly shrunk. A face that has lost its expressiveness. These are not random observations, they are the disease announcing itself in a language most people do not yet know how to read.

This blog is about learning that language early, because in Parkinson’s disease, early is everything.

At Graphic Era Hospital, our Neurology department in Dehradun evaluates and manages Parkinson’s disease across all stages, with a focus on early intervention that meaningfully changes the trajectory of care.

What is Parkinson’s Disease?

Parkinson’s disease is a progressive neurodegenerative condition caused by the gradual loss of dopamine-producing neurons in a part of the brain known as the substantia nigra. Dopamine is the chemical messenger that enables smooth, coordinated movement. As its levels decline, the brain’s ability to regulate movement becomes impaired, leading to the characteristic motor symptoms associated with the condition.

What is less commonly understood is that Parkinson’s is not purely a motor disorder. The same degenerative process affects multiple brain systems, resulting in a wide range of non-motor symptoms, such as changes in mood, loss of smell, sleep disturbances, digestive issues, and cognitive changes.

Most cases of Parkinson’s disease are idiopathic, meaning no single identifiable cause can be determined. A smaller proportion is linked to genetic mutations, certain medications, or related conditions known as atypical parkinsonian disorders, such as Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). While these conditions may resemble Parkinson’s in the early stages, they differ in progression and response to treatment.

Parkinson’s is often misunderstood in India, as it is commonly seen as a disease of old age or one more prevalent in Western populations. Both assumptions are misleading. India carries a significant and growing burden of Parkinson’s disease. Early-onset Parkinson’s, diagnosed before the age of 50, is more common than widely recognised. Research from centres such as NIMHANS has highlighted a notable proportion of younger patients, with genetic factors playing a more prominent role in this group.

Parkinson’s disease is not rare in India. It is underdiagnosed.

The Early Warning Signs Most People Miss

The early warning signs can appear 5 to 10 years before a formal Parkinson’s diagnosis. They are non-motor in nature, which means they have nothing obvious to do with movement, and that is precisely why they get missed, dismissed, or attributed to something else entirely. Early warning signs most people miss include:

Loss of Smell (Anosmia)

One of the earliest and most consistent predictors of Parkinson’s disease is a reduced or complete loss of the sense of smell, unrelated to a cold, allergy, or sinus condition. The same protein, alpha-synuclein, that accumulates in the dopamine-regulating regions of the brain also accumulates in the olfactory bulb, the part of the brain that processes smell, very early in the disease process.

A persistent, unexplained loss of smell (idiopathic anosmia) is increasingly recognised as an early signal of Parkinson’s disease. According to neurologists at Johns Hopkins, individuals with idiopathic anosmia may have up to a 50% likelihood of developing Parkinson’s within the next five to ten years.

In daily life, this is often presented subtly. Food may begin to taste bland. Familiar, strong smells, such as petrol, perfume, or spices, may go unnoticed. In many cases, family members recognise these changes before the individual does.

Good to Know: If you or someone close to you has experienced a persistent, unexplained decline in the sense of smell, it is worth mentioning to a neurologist. It may not indicate anything serious, but it may also be an early signal that deserves further evaluation.

REM Sleep Behaviour Disorder

During normal sleep, the body enters a state of temporary muscle paralysis during the REM (dreaming) phase, preventing people from physically acting out their dreams. In REM Sleep Behaviour Disorder (RBD), this paralysis fails. The person shouts, kicks, punches, or leaps out of bed in the middle of what appears to be a vivid, often violent dream, and frequently remembers it clearly upon waking.

This is almost always reported by a spouse or bed partner, not the person themselves. It is disruptive, sometimes dangerous, and often attributed to stress or an “overactive mind.” It is, in fact, one of the strongest early predictors of Parkinson’s disease. People with idiopathic RBD carry at least a 50% lifetime risk of developing a synucleinopathy – the category of neurodegenerative conditions that includes Parkinson’s.

Chronic Constipation

Constipation that is persistent, unrelated to dietary changes, and unresponsive to the usual remedies is a recognised prodromal symptom of Parkinson’s disease. The enteric nervous system, the complex network of neurons lining the gut, is affected early by the same degenerative process that later reaches the brain. In fact, some researchers believe Parkinson’s may begin in the gut, with the disease progressing upward to the brain over years.

In India, where constipation is frequently attributed to diet, hydration, or lifestyle, this connection is almost universally missed.

Micrographia – The Shrinking Handwriting

Micrographia refers to a characteristic change in handwriting seen in the early stages of Parkinson’s disease, reflecting a decline in fine motor control. The change is not simply messiness. Writing becomes progressively smaller, with letters crowding together and words compressing towards the end of a line, as though the hand is losing momentum mid-sentence. A line that begins at a normal size often tapers into cramped, miniature script.

This is not a typical effect of ageing or arthritic changes in the hands. A simple comparison can be revealing, for example look at a cheque signature or a handwritten note from a few years ago and compare it with recent writing. If the newer writing is consistently smaller, tighter, and more compressed, it may point to an underlying neurological change.

If such a pattern is noticeable, it is worth discussing with a neurologist.

Masked Face (Hypomimia)

The human face is constantly expressive – conveying warmth, concern, humour, and engagement through subtle, involuntary muscle movements. In Parkinson’s disease, as motor control is affected, these micro-expressions gradually diminish. The face may appear less animated, less responsive, and noticeably reduced in emotional expression during conversation.

This change is often misinterpreted. Families may feel the person seems disinterested, withdrawn, or even irritable. Comments such as, “He looks bored when I speak,” or “She never smiles anymore,” are common. Because the change is gradual, it is frequently attributed to mood shifts or personality changes rather than an underlying neurological cause. Over time, this misunderstanding can quietly strain relationships.

Masked face is not an emotional state; it is a neurological symptom. Recognising this distinction early can help families respond with understanding and ensure that the change is discussed with a neurologist.

Soft or Monotone Voice

A voice that has become noticeably quieter, flatter in tone, or less expressive, without any throat or respiratory condition to explain it, is an early motor sign that often develops before the more classic symptoms appear. The person may not notice it themselves; family members are usually the first to observe that they are asking “can you speak up?” more frequently than before.

Mood Changes: Depression and Anxiety

Late-onset depression or anxiety, appearing for the first time in someone’s 50s or 60s, with no prior history of either, is a recognised non-motor prodromal symptom of Parkinson’s disease. These are not simply emotional responses to ageing or life stress. They reflect neurochemical changes in the brain that are part of the same degenerative process. Treating them as purely psychiatric conditions, without investigating their neurological context, delays the full picture.

The Classic Motor Symptoms: What Most People Already Know

Once Parkinson’s progresses into its motor phase, the following symptoms become more apparent. These are the signs most people associate with the disease, but by the time they appear, the non-motor phase has typically been underway for years.

• Resting Tremor: The most recognisable sign – a rhythmic, involuntary shaking of the hand, finger, or chin that occurs when the limb is at rest and often reduces during purposeful movement. It typically begins on one side of the body. Not every person with Parkinson’s develops a tremor, and its absence does not rule out the diagnosis.
• Bradykinesia: Slowness of movement. Tasks that were once automatic, buttoning a shirt, getting up from a chair, walking across a room, take noticeably longer and require greater effort. This is a core feature of Parkinson’s and one of the primary criteria for clinical diagnosis.
• Rigidity: Stiffness in the muscles of the arms, legs, or trunk, sometimes accompanied by aching in the shoulder, hip, or neck. This is frequently misattributed to arthritis or a musculoskeletal injury, particularly in the early stages.
• Postural Instability: Difficulty with balance and coordination, a tendency to stoop or lean forward when standing, and an increased risk of falls. This typically emerges in the middle stages of the disease.

Note: A resting tremor is often the most noticeable early sign. Bradykinesia (slowness of movement) and rigidity are far more subtle, particularly in the early stages. As a result, many people are initially told they have arthritis, a frozen shoulder, or are simply “getting older” before Parkinson’s is even considered.

Parkinson’s Disease Stages: Understanding the Progression

Parkinson’s is staged using the Hoehn and Yahr scale, which provides a broad framework for understanding how the disease progresses and what level of support a person may require at each point.

The clinical value of early diagnosis, at Stage 1 or 2, is substantial. Medication at this stage is more effective, side effects are more manageable, and the window for exercise-based neuroprotection is widest. Every stage of early intervention changes the trajectory of what follows.

Parkinson’s vs. Alzheimer’s: Clearing Up the Confusion

Both are progressive neurological conditions that primarily affect older adults, and families sometimes struggle to distinguish between them — particularly in the early stages when symptoms overlap. They are, fundamentally, different diseases.

The distinction matters because management strategies, medication choices, and long-term care planning differ significantly between the two. In advanced Parkinson’s disease, a proportion of patients may develop dementia, which can create genuine diagnostic overlap. This makes early and accurate diagnosis by a neurologist especially important.

How is Parkinson’s Disease Diagnosed?

There is no single blood test or scan that definitively confirms Parkinson’s disease. Diagnosis is primarily clinical and is based on a detailed neurological evaluation, a thorough symptom history, and the careful exclusion of other conditions that can present in a similar way.

The diagnostic process typically involves the following:

Neurological Examination

This forms the cornerstone of diagnosis. A neurologist evaluates motor function, reflexes, gait, posture, facial expression, and speech, looking for a characteristic pattern of signs consistent with Parkinson’s disease.

MRI Brain

An MRI does not diagnose Parkinson’s directly but is essential to rule out other causes of similar symptoms, such as structural brain lesions, vascular changes, or normal pressure hydrocephalus. At Graphic Era Hospital, a 3 Tesla MRI, considered among the most advanced imaging systems available in the region, is operational 24×7 and plays a key role in neurological evaluation.

Response to Levodopa

A clear and sustained improvement with levodopa supports the diagnosis of idiopathic Parkinson’s disease. In contrast, atypical parkinsonian disorders often show a limited or absent response.

DaTscan (Dopamine Transporter Scan)

This specialised nuclear imaging test assesses dopamine transporter activity in the brain. It is particularly useful in distinguishing Parkinson’s disease from conditions that mimic it and is typically used when the clinical picture remains uncertain.

Treatment and Self-Care: Managing Life With Parkinson’s

Parkinson’s disease is not curable, but it is very manageable, and the range of tools available in 2026 is broader than at any previous point in the disease’s clinical history. Managing life with Parkinson’s include:

Medications

Levodopa combined with carbidopa remains the most effective treatment for Parkinson’s symptoms, replacing the dopamine the brain can no longer produce adequately. Dopamine agonists and MAO-B inhibitors are used alongside or as alternatives depending on age, disease stage, and individual response. Medication management in Parkinson’s requires ongoing adjustment as the disease progresses, and a neurologist’s involvement is essential throughout.

Deep Brain Stimulation (DBS)

For patients with advanced Parkinson’s whose symptoms are no longer adequately controlled by medication, Deep Brain Stimulation offers a meaningful intervention. DBS involves the surgical implantation of electrodes that deliver targeted electrical impulses to specific brain regions, modulating the abnormal signals that produce tremor and rigidity. It does not cure the disease or stop its progression, but it can significantly improve quality of life and reduce medication dependency in carefully selected patients. At Graphic Era Hospital, access to advanced neurosurgical care means that patients who reach this stage of the disease do not need to travel far for evaluation and management.

Physiotherapy, Speech Therapy, and Occupational Therapy

Rehabilitation is not a last resort; it is an ongoing, active component of Parkinson’s management from the earliest stages. Physiotherapy targets gait, balance, and motor coordination. Speech therapy addresses the soft, monotone voice and swallowing difficulties that emerge with progression. Occupational therapy supports independence in daily tasks as dexterity and movement become more challenging.

Exercise

Exercise is one of the most robustly evidence-backed interventions in Parkinson’s disease management. Regular aerobic exercise, balance training, and activities such as tai chi and dancing have been shown to slow motor decline, improve balance, and support mood. The earlier it begins, the more meaningful its effect.

Diet and Nutrition

A balanced, fibre-rich diet supports gut motility and addresses the constipation that is both an early symptom and an ongoing management challenge. Adequate hydration matters. Protein intake timing may need adjustment for patients on levodopa, as large protein meals can interfere with medication absorption – a point worth discussing with both a neurologist and a dietitian.

Managing Anxiety and Insomnia

Both anxiety and insomnia are legitimate non-motor symptoms of Parkinson’s, not simply psychological responses to living with a chronic illness. They require active management as part of the overall care plan, through a combination of medication, structured sleep hygiene, and psychological support where appropriate.

When to See a Neurologist

Do not wait for a tremor. Seek a neurological evaluation if any of the following apply:

• A persistent, unexplained loss of smell with no sinus or respiratory cause
• A bed partner or family member reports that you physically act out dreams during sleep
• Handwriting has become noticeably smaller and more cramped over time
• Chronic constipation that does not respond to dietary changes
• A face that has become less expressive, noticed by family members rather than the person themselves
• Late-onset depression or anxiety with no prior history
• Any motor symptoms, slowness, stiffness, a resting tremor, even if mild
• A family history of Parkinson’s disease

Early consultation does not guarantee an early diagnosis, but it creates the opportunity for one. And in Parkinson’s disease, that opportunity is the most valuable thing available.

At Graphic Era Hospital’s Neurology department, our specialists evaluate Parkinson’s presentations with the clinical rigour and imaging support needed to reach a confident diagnosis and begin the right management plan as early as possible.

Early is Not Just a Preference. It is the Point.

Parkinson’s disease is not curable. However, it is manageable, and many people continue to live with dignity, independence, and a good quality of life for years. The difference between a well-managed journey and a more difficult one often comes down to one factor: how early diagnosis and care begin.

The tremor most people associate with Parkinson’s is rarely the beginning. It is simply the point at which the condition becomes visible. The true onset is quieter, with signs such as a change in handwriting, a less expressive face, disturbed sleep, or a fading sense of smell. These early shifts are easy to overlook, but they are also the window where timely intervention can meaningfully influence what comes next.

If something feels different in yourself or in someone close to you, do not wait for certainty. Bring it to a neurologist. Early evaluation allows for accurate diagnosis and timely management, which can significantly improve long-term outcomes.

To consult a neurologist or schedule an evaluation, call 1800 889 7351 (24×7).